CULLINAN THERAPEUTICS Trademark
Trademark Overview
On Monday, August 26, 2024, a trademark application was filed for CULLINAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CULLINAN THERAPEUTICS trademark a serial number of 98717377. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, September 10, 2025. This trademark is owned by Cullinan Therapeutics, Inc.. The CULLINAN THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology
Pharmaceutical research and development; scientific research and development; medical research and development in the fields of oncology, autoimmunity, and immunology; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology
General Information
| Serial Number | 98717377 |
| Word Mark | CULLINAN THERAPEUTICS |
| Filing Date | Monday, August 26, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, September 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the literal elements CULLINAN THERAPEUTICS with a stylized wing appearing over the "I" in CULLINAN. |
| Goods and Services | Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology |
| Section 2(f) Limitation Statement | CULLINAN has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement. CULLINAN has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 7797946 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Pharmaceutical research and development; scientific research and development; medical research and development in the fields of oncology, autoimmunity, and immunology; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, May 31, 2024 |
| First Use In Commerce Date | Friday, May 31, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 10, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, May 31, 2024 |
| First Use In Commerce Date | Friday, May 31, 2024 |
Trademark Owner History
| Party Name | Cullinan Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Monday, August 26, 2024 | NEW APPLICATION ENTERED |
| Wednesday, February 26, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, February 26, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 3, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 10, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, March 10, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 10, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 28, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, May 28, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, September 10, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 10, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 10, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
